These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32593649)

  • 1. Optimization of inhalable liposomal powder formulations and evaluation of their in vitro drug delivery behavior in Calu-3 human lung epithelial cells.
    Yu S; Yuan H; Chai G; Peng K; Zou P; Li X; Li J; Zhou F; Chan HK; Zhou QT
    Int J Pharm; 2020 Aug; 586():119570. PubMed ID: 32593649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
    Yu S; Wang S; Zou P; Chai G; Lin YW; Velkov T; Li J; Pan W; Zhou QT
    Int J Pharm; 2020 Feb; 575():118915. PubMed ID: 31816354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
    Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
    Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model.
    Chai G; Park H; Yu S; Zhou F; Li J; Xu Q; Zhou QT
    Int J Pharm; 2019 Oct; 569():118616. PubMed ID: 31415873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.
    Yu S; Pu X; Ahmed MU; Yu HH; Mutukuri TT; Li J; Zhou QT
    Int J Pharm; 2021 Dec; 610():121160. PubMed ID: 34624446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of ciprofloxacin nanocrystals within liposomes by spray drying for controlled release via inhalation.
    Khatib I; Tang P; Ruan J; Cipolla D; Dayton F; Blanchard JD; Chan HK
    Int J Pharm; 2020 Mar; 578():119045. PubMed ID: 31981702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial profiling of antibiotic controlled release respiratory formulations.
    Ong HX; Traini D; Bebawy M; Young PM
    Pharm Res; 2011 Sep; 28(9):2327-38. PubMed ID: 21614637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.
    Mangal S; Huang J; Shetty N; Park H; Lin YW; Yu HH; Zemlyanov D; Velkov T; Li J; Zhou QT
    Int J Pharm; 2019 Apr; 561():102-113. PubMed ID: 30797863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
    Ong HX; Benaouda F; Traini D; Cipolla D; Gonda I; Bebawy M; Forbes B; Young PM
    Eur J Pharm Biopharm; 2014 Jan; 86(1):83-9. PubMed ID: 23851077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Formulation Reduces Transport and Cell Uptake of Colistin in Human Lung Epithelial Calu-3 Cell and 3D Human Lung Primary Tissue Models.
    Huang Y; Yu S; Ahmed MU; Zhou QT
    AAPS PharmSciTech; 2024 Feb; 25(3):40. PubMed ID: 38366100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
    Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
    Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.
    Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):49-60. PubMed ID: 28708440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in liposomal dry powder formulations: preparation and evaluation.
    Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
    Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming dose limitations using the orbital(®) multi-breath dry powder inhaler.
    Young PM; Crapper J; Philips G; Sharma K; Chan HK; Traini D
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):138-47. PubMed ID: 24004178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
    Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Storage stability of inhalable, controlled-release powder formulations of ciprofloxacin nanocrystal-containing liposomes.
    Khatib I; Ke WR; Cipolla D; Chan HK
    Int J Pharm; 2021 Aug; 605():120809. PubMed ID: 34144139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery.
    Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH
    Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling.
    Ling J; Mangal S; Park H; Wang S; Cavallaro A; Zhou QT
    J Pharm Sci; 2019 Sep; 108(9):3146-3151. PubMed ID: 31112716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.
    Ong HX; Traini D; Cipolla D; Gonda I; Bebawy M; Agus H; Young PM
    Pharm Res; 2012 Dec; 29(12):3335-46. PubMed ID: 22833052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.